Clinical trial Recruiting at 9 sites Observational Ages 18 and up

Using ziconotide for treating severe chronic pain not related to cancer

Official title: Ziconotide for Non-cancer Pain by Intrathecal Administration

Run by ESTEVE Pharmaceuticals SAS · NCT06541184 · Data updated 2026-11-12

This study is trying to see if ziconotide can safely help people with severe chronic pain that isn't related to cancer.

More Pain, Chronic trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment85 (estimated)
SponsorESTEVE Pharmaceuticals SAS
Industry-sponsored
Drugs / interventionschemotherapy
Locations14 sites (Aubagne and 13 other locations)
StatusRecruiting
StartedOctober 30, 2024
Main results expectedOctober 30, 2029
Study endsOctober 30, 2029
Registry record updatedFebruary 27, 2025
Trial IDNCT06541184 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older suffering from chronic non-cancer pain that requires interventional treatment.

Probably not a fit

Patients who have contraindications to intrathecal therapy or ziconotide, or those unable to participate in data collection, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to gather data on patients suffering from chronic non-cancer pain who are treated with ziconotide-based intrathecal analgesia. The study seeks to document the effectiveness and safety of ziconotide in this population, as its use has primarily been associated with cancer pain management. By collecting information from both current users of ziconotide and new candidates for treatment, the registry hopes to provide valuable insights that could guide future clinical decisions. The study addresses the gap in knowledge regarding the use of ziconotide for non-cancer pain, which is often overlooked due to a lack of comprehensive data.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option for patients with severe chronic pain who have not responded to standard therapies.

How similar studies have gone: While ziconotide has been primarily studied in cancer pain, this approach for non-cancer pain is less documented, indicating a novel exploration in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years,
2. Chronic non-cancer pain requiring interventional techniques, and eligible to ziconotide-containing intrathecal therapy,
3. Having received information on and not opposed to data collection,

Inclusion criteria specific for the retrospective cohort:

Currently treated by ziconotide-based ITA according to SmPC whatever the duration of treatment

Inclusion criteria specific for the prospective cohort:

Naïve of ITA and candidate to ziconotide-based ITA or already treated by IT route without ziconotide, scheduled for addition of ziconotide in the pump

Exclusion Criteria:

1. Contraindication to intrathecal therapy or to ziconotide
2. Any condition that may jeopardize appropriate follow-up of the treatment
3. Patient under guardianship or deprived of liberty by a judicial or administrative decision or unable to express opposition to data collection.

Where it's running

  • Clinique de la Casamance
    Aubagne, France
    Recruiting
  • Hospices Civils de Lyon
    Bron, France
    Recruiting
  • CHD Vendée
    La Roche-sur-Yon, France
    Recruiting
  • CH Laon
    Laon, France
    Recruiting
  • CHU Lille
    Lille, France
    Recruiting
  • Clinique Mutualiste de la Porte de l'Orient
    Lorient, France
    Recruiting
Show 8 more locations
  • Centre Léon Bérard
    Lyon, France
    Recruiting
  • CH Yves Le foll
    Saint-Brieuc, France
    Recruiting
  • CHU St Etienne
    Saint-Etienne, France
    Recruiting
  • Polyclinique du Parc
    Caen, France
    Not yet recruiting
  • Hopital Saint Joseph
    Paris, France
    Not yet recruiting
  • CHU Poitiers
    Poitiers, France
    Not yet recruiting
  • CHU Reims
    Reims, France
    Not yet recruiting
  • IUCT Toulouse
    Toulouse, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.